Last reviewed · How we verify
Amlodipine-FA tablet,high dose group
Amlodipine-FA tablet works by inhibiting the L-type calcium channels in smooth muscle cells, leading to vasodilation and reduced blood pressure.
Amlodipine-FA tablet works by inhibiting the L-type calcium channels in smooth muscle cells, leading to vasodilation and reduced blood pressure. Used for Hypertension, Angina pectoris.
At a glance
| Generic name | Amlodipine-FA tablet,high dose group |
|---|---|
| Also known as | high dose |
| Sponsor | Shenzhen Ausa Pharmed Co.,Ltd |
| Drug class | Calcium channel blocker |
| Target | L-type calcium channels |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 2 |
Mechanism of action
This results in decreased peripheral resistance and a subsequent decrease in blood pressure. Amlodipine-FA tablet is a calcium channel blocker, which is a class of medications that work by blocking the influx of calcium ions into smooth muscle cells, leading to vasodilation and reduced blood pressure.
Approved indications
- Hypertension
- Angina pectoris
Common side effects
- Edema
- Dizziness
- Headache
Key clinical trials
- Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine (PHASE2, PHASE3)
- Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: